Has John Hatheway, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,896,349 in general payments to John Hatheway, MD across 1,806 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Hatheway, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Hatheway, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Hatheway, MD

Interventional Pain Medicine · Coeur D Alene, IDNPI 1720078678

Payments from drug & device makers

$1,896,349in general payments, 2019–2025

Across 1,806 payments — averaging $1050.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$909K
Nalu Medical, Inc.$764K
Boston Scientific$175K
Biotronik Inc.$21K
Genesys Orthopedics Systems, L.L.C.$10K
Si-bone, Inc.$9K
plus $9K from 21 others

$1,490in research payments, 2019–2025

Across 2 payments — averaging $745.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genesys Orthopedics Systems, L.L.C.$1K

What the payments were for

Consulting fees$249,12031%
Speaking & faculty fees$435,35354%
Travel & lodging$82,48510%
Food & beverage$32,9064%
Education$800%
Gifts$290%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	884	$909,124
Nalu Medical, Inc.	297	$764,204
Boston Scientific	181	$175,125
Biotronik Inc.	301	$20,735
Genesys Orthopedics Systems, L.L.C.	16	$9,528
Si-bone, Inc.	13	$8,981
Southern Spine, LLC	1	$2,500
Abbott	15	$1,574
Stimwave Technologies Incorporated	8	$805
Relievant Medsystems, Inc.	15	$744
Nevro Corp.	5	$502
Tersera Therapeutics LLC	15	$413
Biotronik NRO, Inc.	5	$336
Vertos Medical, Inc.	4	$317
Vertiflex, Inc.	6	$249
Radius Health, Inc.	8	$239
AbbVie(2 entities)	13	$227
SPR Therapeutics, Inc	5	$194
Pacira Therapeutics, Inc.	2	$164
Zimvie Inc.	1	$134
Spinal Simplicity, LLC	2	$75
Stryker	1	$56
MDD US Operations, LLC	2	$32
Biodelivery Sciences International, Inc.	2	$31
GRT US Holding, Inc.	2	$24
Amgen	1	$22
Takeda Pharmaceuticals U.S.A., Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Nalu Neurostimulation System$217,754
INTELLIS ADAPTIVESTIM$125,254
SYNCHROMED$78,494
INTELLIS$58,999
SUPERION$57,597
KYPHON EXPRESS II KYPHOPAK TRAY$48,228
VERIFLEX$28,875
SYNCHROMEDII$26,077
Superion Indirect Decompression System$25,043
RESTORE$14,778
VANTA ADAPTIVESTIM$14,255
SACROILIAC JOINT FUSION SYSTEM$9,257
ADAPTIVESTIM$5,295
GENERAL - THERAPIES$3,769
OSTEOCOOL RF ABLATION$3,750
GENERAL PAIN MANAGEMENT$2,876
SPECTRA WAVEWRITER$2,150
Accurian$1,892
Proclaim Family of SCS IPGs$1,220
KYPHON Balloon Kyphoplasty$1,149

How this compares

Too few interventional pain medicine providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$364,717

Medicare patients

283

Services billed

4,322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	25	$530
Mupirocin	44	$421
Cyclobenzaprine Hcl	14	$267
Pregabalin	12	$225
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	12	$73

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Coeur D Alene

Russell HarmonyMeridian$17K
Craig FlindersLewiston$13K
Shane MaxwellMeridian$6K
Karl ZarseMeridian$6K
Lyndal StoutinLewiston$3K
Christian BeckerIdaho Falls$66
Patrick FarrellBoise$15

See the full list for Idaho →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →